First Page | Document Content | |
---|---|---|
![]() Date: 2016-03-02 15:52:19Medicine Clinical medicine Neurochemistry Amphetamine Substituted amphetamines TAAR1 agonists Euphoriants Anorectics Lisdexamfetamine Dextroamphetamine Stimulant Anorexia | Add to Reading List |
![]() | VYVANSE® [Vī’ - văns] MEDICATION GUIDE (lisdexamfetamine dimesylate) CII Capsules What is the most important information I should know aboutDocID: 1tcsc - View Document |
![]() | prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORTDocID: 1pBj0 - View Document |
![]() | prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management ofDocID: 1ou1z - View Document |
![]() | Microsoft Word - VYVANSE.Product MonographdocDocID: 1m5V8 - View Document |
![]() | Patient Assistance Program Shire Pharma Canada ULC (“Shire”) developed the VYVANSE Patient Assistance Program (the “Program”) for Canadian patients requiring support by covering for tDocID: 1lpLs - View Document |